Health and Plant Protein Group Limited

ASX:HPP Stock Report

Market Cap: AU$5.2m

Health and Plant Protein Group Past Earnings Performance

Past criteria checks 0/6

Health and Plant Protein Group has been growing earnings at an average annual rate of 23.6%, while the Food industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 29.1% per year.

Key information

23.6%

Earnings growth rate

33.8%

EPS growth rate

Food Industry Growth5.9%
Revenue growth rate-29.1%
Return on equity-88.3%
Net Marginn/a
Last Earnings Update30 Jun 2023

Recent past performance updates

Health and Plant Protein Group's (ASX:HPP) Shareholders May Want To Dig Deeper Than Statutory Profit

Mar 07
Health and Plant Protein Group's (ASX:HPP) Shareholders May Want To Dig Deeper Than Statutory Profit

Recent updates

Is Health and Plant Protein Group (ASX:HPP) Using Debt In A Risky Way?

Jun 20
Is Health and Plant Protein Group (ASX:HPP) Using Debt In A Risky Way?

Health and Plant Protein Group's (ASX:HPP) Shareholders May Want To Dig Deeper Than Statutory Profit

Mar 07
Health and Plant Protein Group's (ASX:HPP) Shareholders May Want To Dig Deeper Than Statutory Profit

Estimating The Fair Value Of Health and Plant Protein Group Limited (ASX:HPP)

Dec 13
Estimating The Fair Value Of Health and Plant Protein Group Limited (ASX:HPP)

Is Health and Plant Protein Group (ASX:HPP) A Risky Investment?

Aug 30
Is Health and Plant Protein Group (ASX:HPP) A Risky Investment?

Here's Why Health and Plant Protein Group (ASX:HPP) Has A Meaningful Debt Burden

May 11
Here's Why Health and Plant Protein Group (ASX:HPP) Has A Meaningful Debt Burden

Auditors Are Concerned About Health and Plant Protein Group (ASX:HPP)

Sep 06
Auditors Are Concerned About Health and Plant Protein Group (ASX:HPP)

Is Health and Plant Protein Group (ASX:HPP) Using Too Much Debt?

Mar 08
Is Health and Plant Protein Group (ASX:HPP) Using Too Much Debt?

How Many Health and Plant Protein Group Limited (ASX:HPP) Shares Did Insiders Buy, In The Last Year?

Jan 14
How Many Health and Plant Protein Group Limited (ASX:HPP) Shares Did Insiders Buy, In The Last Year?

Revenue & Expenses Breakdown
Beta

How Health and Plant Protein Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:HPP Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 230-650
31 Mar 230-440
31 Dec 22422110
30 Sep 22421110
30 Jun 220-230
31 Mar 229-750
31 Dec 2119-1180
30 Sep 2127-11100
30 Jun 2136-11120
31 Mar 2137-8120
31 Dec 2037-5110
30 Sep 2040-4110
30 Jun 2042-2100
31 Dec 1931-260
30 Sep 1936-180
30 Jun 19420100
31 Dec 1864-13180
30 Sep 1860-15170
30 Jun 1856-17160
31 Dec 1748-4150
30 Sep 1748-7150
30 Jun 1747-9140
31 Mar 1758-11140
31 Dec 1663-13140
30 Sep 1671-10150
30 Jun 1679-7160
31 Mar 1677-5160
31 Dec 1576-3170
30 Sep 1573-1160
30 Jun 15710150
31 Mar 15670140
31 Dec 14630130
30 Sep 1463-1130
30 Jun 1463-1130
30 Jun 13600150
31 Dec 12762170

Quality Earnings: HPP is currently unprofitable.

Growing Profit Margin: HPP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HPP is unprofitable, but has reduced losses over the past 5 years at a rate of 23.6% per year.

Accelerating Growth: Unable to compare HPP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HPP is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (-19.2%).


Return on Equity

High ROE: HPP has a negative Return on Equity (-88.28%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.